Pediatrics | CHOP Research Institute
 

Pediatrics

Published on
Oct 3, 2023
With $50 million in NIH funding, the research team will recruit and follow 2,500 pregnant patients and their children for the next seven years.
Published on
May 26, 2023
In this week’s news roundup, CHOP’s Department of Pediatrics ranked No 1. in U.S. News & World Report’s ‘Best Pediatrics Programs’ for medical schools.
Published on
May 5, 2023
The American Pediatric Society honored Dr. Feudtner for his contributions to pediatric sciences.
Published on
Feb 28, 2022
From bench to bedside, Dr. Bhoj studies rare genetic disorders, particularly neurologic syndromes.

Addressing public concerns and existing gaps in the basic and clinical science related to the natural history, evaluation and management, and prevention of sports-related concussion.

Published on
Nov 23, 2020
Evaluating data from collaborating PEDSnet institutions yields epidemiological insight into SARS-CoV-2.
Published on
Jun 21, 2020
Dr. St. Geme builds upon his father’s legacy to advance child health with his own research contributions and a focus on holistic care.

The Bhoj Lab discovers new human disease genes, their mechanisms, and potential targeted therapies. A bedside-to-bench-to-bedside translational lab that brings discoveries back to patients, we are focused on three novel genes that lead to pediatric neurologic dysfunction: TBCK, H3F3A/B, and MAP4K4.

Published on
Jun 18, 2019
The Symposium on Advances in Genomic, Epidemiology, and Statistics shares analytical methods for genomics and other high-dimensional data research fields.

Dr. Bhoj's genetics research aims to discover new human disease genes, their mechanisms, and potential targeted therapies. In addition to ongoing gene discovery efforts, Dr. Bhoj focuses on three novel genes that lead to pediatric neurologic dysfunction: TBC1 domain-containing kinase, Histone 3.3 (H3F3A and H3F3B), and MAP4K4.

E-mail:
bhoje [at] chop.edu